Three European countries on Thursday said they would hold off on resuming usage of the Oxford-AstraZeneca COVID-19 vaccine even after the bloc’s drug regulator said the benefits of the vaccine outweigh the negative side effects and cleared it for use. Denmark, Norway, and Sweden, in separate statements, said they would wait on whether to decide if they would resume rolling out the vaccine. Reports said that some recipients of the vaccine developed blood clots or died after getting the shot. In Italy, a prosecutor in Piedmont announced they would open a criminal manslaughter investigation after a 57-year-old music teacher died hours after getting the AstraZeneca CCP virus shot, while Danish officials last week said a 60-year-old woman developed “unusual symptoms” and died after the shot. Amid the reports, more than a dozen European Union countries suspended usage of the vaccine, including Italy, Germany, France, Spain, the Netherlands, Denmark, Sweden, and others. …